Neurocognitive Dysfunction clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli
open to eligible people ages 18 years and up
This study is a prospective, multicenter, randomized (1:1) controlled comparative effectiveness trial of a transseptal approach to left ventricular ablation compared to a retrograde aortic approach to prevent cerebral emboli and neurocognitive decline in adults with ventricular tachycardia (VT) and/or premature ventricular contractions (PVCs).
San Francisco, California and other locations
Our lead scientists for Neurocognitive Dysfunction research studies include Gregory Marcus.
Last updated: